These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5255181)

  • 1. Comparison of perphenazine and P-5227 in chronic schizophrenics: clinical and EEG effects.
    Holden JM; Itil TM; Keskiner A
    J Clin Pharmacol J New Drugs; 1969; 9(3):163-75. PubMed ID: 5255181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R; Wegener G
    Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of doxepin in anxious depressed outpatients.
    Goldstein BJ; Pinosky DG
    Curr Ther Res Clin Exp; 1969 Apr; 11(4):169-77. PubMed ID: 4976335
    [No Abstract]   [Full Text] [Related]  

  • 4. Protrptyline in the treatment of chronic schizophrenic patients.
    Arbitman R; Yurtcu A; Lehmann HE; Sterlin C; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):131-5. PubMed ID: 4985491
    [No Abstract]   [Full Text] [Related]  

  • 5. Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative study.
    Sterlin C; Augustin E; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):50-2. PubMed ID: 4992566
    [No Abstract]   [Full Text] [Related]  

  • 6. A study with Sinequan (Doxepin).
    Koknel O; Eper O
    Dis Nerv Syst; 1971 Jun; 32(6):405-8. PubMed ID: 5570694
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe emotional disturbance associated with physical illness. I. Double-blind study.
    Coleman J
    Psychosomatics; 1969; 10(3):32-5. PubMed ID: 4898444
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double blind study of clopenthixol and chlorpromazine in acute hospitalized schizophrenics.
    Kingstone E; Kolivakis T; Kossatz I
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):41-5. PubMed ID: 4909377
    [No Abstract]   [Full Text] [Related]  

  • 10. A double blind controlled trial of thiothixene and perphenazine in chronic schizophrenics shown to require maintenance therapy.
    Kellam AM; Jones KS
    Acta Psychiatr Scand; 1971; 47(2):174-85. PubMed ID: 4947996
    [No Abstract]   [Full Text] [Related]  

  • 11. A blind comparison of clozapine and perphenazine in schizophrenics.
    Rodová A; Svestka J; Náhunek K; Cesková E
    Act Nerv Super (Praha); 1973 May; 15(2):94-5. PubMed ID: 4752682
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial.
    Lepola U; Koskinen T; Rimón R; Salo H; Gordin A
    Acta Psychiatr Scand; 1989 Jul; 80(1):92-6. PubMed ID: 2669445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a protriptyline-perphenazine combination in chronic psychiatric patients.
    St-Jean A; Ban TA; Scott J
    Curr Ther Res Clin Exp; 1966 Oct; 8(10):483-6. PubMed ID: 4961168
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perphenazine enanthate in the treatment of chronic schizophrenia].
    Kampman R; Leppäluoto V
    Duodecim; 1970; 86(20):1167-70. PubMed ID: 5477736
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.
    Bora G
    Dis Nerv Syst; 1968 Oct; 29(10):695-7. PubMed ID: 4887393
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829
    [No Abstract]   [Full Text] [Related]  

  • 17. Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
    Kistrup K; Gerlach J; Aaes-Jørgensen T; Larsen NE
    Psychopharmacology (Berl); 1991; 105(1):42-8. PubMed ID: 1745710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of LSD and ditran in the treatment of therapy resistant schizophrenics (symptom provocation approach).
    Itil TM; Keskiner S; Holden JM
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:93-103. PubMed ID: 4388281
    [No Abstract]   [Full Text] [Related]  

  • 19. A sequential comparison of amitriptyline, perphenazine and the amitriptyline-perphenazine combination in recently admitted anergic schizophrenics.
    Vestre ND; Dehnel LL; Schiele BC
    Psychosomatics; 1969; 10(5):296-303. PubMed ID: 4390779
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities.
    Neppe VM
    J Clin Psychiatry; 1983 Sep; 44(9):326-31. PubMed ID: 6355069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.